Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05514847 · ClinicalTrials.gov registry record · Phase 4
Low Dose Aspirin for Preterm Preeclampsia Preventionmg/day Dose in High-risk Patients
A Phase 4 study of Pregnancy Related and Preeclampsia, sponsored by University of Virginia.
- Active
- Registry status
- Phase 4
- Development phase
- 150
- Enrollment target
- 1
- Study location
NCT05514847 is a Phase 4 study of Pregnancy Related and Preeclampsia that is active but no longer recruiting, run by University of Virginia. The registered enrollment target is 150 participants, below the 1,961-participant average among 99 other Pregnancy Related trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05514847, a Phase 4 study of Pregnancy Related and Preeclampsia, is active but no longer recruiting, sponsored by University of Virginia.
- ACTIVE NOT RECRUITING
- Registry status
- Phase 4
- Development phase
- 150 participants
- Enrollment target
- 1
- Study location
Study Summary
This will be a randomized, open-label, controlled trial of patients at high risk of developing preeclampsia examining 81 mg/day vs 162mg/day daily acetylsalicylic acid (ASA) use. Based on screening results, patients will be randomized as outlined below into one of four groups. The proposed study is a pilot to determine if the higher dose of ASA has positive impacts on measures that predict preeclampsia, compared to the lower dose. If positive findings, data from this study could be used to develop a larger trial powered to determine if the higher ASA dose can improve clinical outcomes.
Conditions Studied
Interventions
- DRUG Aspirin 81Mg Ec Tab
- DRUG Aspirin 162Mg Ec Tab
Study Locations (1)
Virginia
- University of Virginia - Charlottesville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2022-10-01 |
| Est. Completion | 2025-12-31 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05514847
The ClinicalTrials.gov registry entry for NCT05514847 describes a study currently listed as active not recruiting, categorized as Phase 4. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,961-participant average among 99 other Pregnancy Related trials with a reported enrollment target (92% lower). The listed sponsor is University of Virginia, which has 449 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Pregnancy Related appearing as the primary indexed condition, and to 2 interventions - of which Aspirin 81Mg Ec Tab is the first listed.
NCT05514847 reports 1 study location spanning 1 distinct geographic area - top geographies include Virginia.
Frequently Asked Questions
What is clinical trial NCT05514847 about?
NCT05514847 is a clinical study titled "Low Dose Aspirin for Preterm Preeclampsia Preventionmg/day Dose in High-risk Patients". This will be a randomized, open-label, controlled trial of patients at high risk of developing preeclampsia examining 81 mg/day vs 162mg/day daily acetylsalicylic acid (ASA) use. Based on screening results, patients will be randomized as outlined below into one of four groups. The proposed study is ...
What is the current status of trial NCT05514847?
This trial is currently active not recruiting. It is a Phase 4 study. The enrollment target is 150 participants. The study started on 2022-10-01. Estimated completion is 2025-12-31.
What conditions does trial NCT05514847 study?
This clinical trial studies the following conditions: Pregnancy Related, Preeclampsia.
What interventions are being tested in trial NCT05514847?
The interventions under investigation include: Aspirin 81Mg Ec Tab (DRUG), Aspirin 162Mg Ec Tab (DRUG).
Who is sponsoring clinical trial NCT05514847?
This trial is sponsored by University of Virginia, which has 449 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05514847 being conducted?
This trial has 1 study location across Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pregnancy Related
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Early Antenatal Support for Iron Deficiency Anemia
RECRUITING · Phase 4
-
Prophylactic Transfusion In Pregnant in Women With Sickle Cell Disease
RECRUITING · Phase 4
-
Perineal Massage Using A Pelvic Wand During Pregnancy
RECRUITING · Phase 4
-
Effects of Pregnancy-associated Hormones on THC Metabolism in Women
ACTIVE NOT RECRUITING · Phase 4
-
Misoprostol Dosing in BMI Greater Than 30
COMPLETED · Phase 4
-
An Observational Retrospective Cohort Study Being Conducted in Women With Atopic Dermatitis Exposed to Ruxolitinib Cream Versus Topical Corticosteroids During Pregnancy: A US Claims Database Analysis
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.